(Reuters) – Boston Scientific said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million.
The deal also includes undisclosed additional payments contingent on sales performance of Relievant over the next three years.
(Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
